RET-IN-15
RET-IN-15 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021115457A1 compound 51. RET-IN-15 can be used for the research of cancer[1].
Product Specifications
CAS Number
2643375-86-2
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ret-in-15.html
Solubility
10 mM in DMSO
Smiles
N#CC1=C2C(C3=CC=C(N4CC(C5)N(CC6=CC=C(OC)N=C6)C5C4)N=C3)=CC(NCCO)=CN2N=C1
Molecular Formula
C27H28N8O2
Molecular Weight
496.56
References & Citations
[1]Chen HM, et, al. Pyrazolo[1,5-a]pyridine compound, preparation method therefor and use thereof. WO2021115457A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
